Effect of peritubular [Ca] or ionomycin on hydrosmotic response of CCTs to ADH or cAMP. Academic Article uri icon

Overview

abstract

  • To evaluate in the mammalian kidney the effect of maneuvers thought to alter intracellular [Ca2+] on the hydraulic conductivity (Lp) response to vasopressin (VP) or 8-(p-chlorophenylthio)-adenosine 3',5'-cyclic monophosphate (ClPheS-cAMP), water flow was measured in isolated perfused rabbit cortical collecting tubules (CCTs) exposed to either varying bath [Ca] or ionomycin or quin 2-acetoxymethyl ester (AM). The development of the response to VP (20 microU/ml) was enhanced 28% by lowering Ca from 1.0 to 0.1 mM, but was not altered by increasing Ca from 1.0 to 3.75 mM. When measured in the same tubule, the maintenance phase of a previously established hormone response was inhibited by acutely raising peritubular Ca from 1.0 to 3.75 mM. Exposing the tubules to 0.1 mM Ca and 65 microM quin 2-AM, inhibited by 68% the development of the response to VP compared with that observed in tubules bathed in 1.0 mM Ca Ringer without quin 2-AM. In contrast, quin 2-AM and low peritubular Ca added during the maintenance phase enhanced the VP response by 50%. The Ca ionophore ionomycin (1.0 microM) reduced the development of the VP-elicited Lp by 65% and reversibly decreased by 42% the maintenance phase of the VP-stimulated Lp in a Ca-dependent manner. A longer exposure to the ionophore was required to inhibit the development and maintenance phases of the response to 10(-4) M ClPheS-cAMP. These results are consistent with the view that transient changes in intracellular [Ca2+] may be required for the development of the hormone response but that sustained increases in cytoplasmic Ca2+ levels inhibit the development as well as the maintenance phase of the hydrosmotic response to VP or cAMP in CCTs.

publication date

  • February 1, 1988

Research

keywords

  • Calcium
  • Cyclic AMP
  • Kidney Tubules
  • Kidney Tubules, Collecting
  • Vasopressins

Identity

Scopus Document Identifier

  • 0023868388

PubMed ID

  • 2830791

Additional Document Info

volume

  • 254

issue

  • 2 Pt 2